Academic Oncologists and the Expanded Access Pathway to Investigational Drugs

Expanded Access is a regulatory pathway that allows seriously ill patients to access investigational drugs outside clinical trials. How do clinicians decide whether and to whom to offer Expanded Access, what resources do they need and where might inequities occur?

This lecture will present the results of qualitative interviews with oncologists practicing at large academic medical centers to shed light on these ethical challenges.

Presented by:
Holly Fernandez Lynch, JD, MBe
Assistant Professor of Medical Ethics and Law
University of Pennsylvania

Discussant:
Lisa Bero, PhD
Chief Scientist, Center for Bioethics and Humanities
Professor of Medicine and Public Health

RSVP Today>>